Stocks Health care ENOV
NYSE · Health careEnovis CORP (ENOV)
Enovis CORP brought in $2.3B of revenue over the twelve months to July 3, 2026, up 4.9% from a year earlier. It posted a net loss of $1.1B. Operating cash flow minus capital spending left $19.9M of free cash flow in fiscal 2025. At July 3, 2026 it held $12.6M in cash against $1.3B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Enovis CORP does
Enovis CORP is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NYSE under the ticker ENOV.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.2B | -$1.2B | -$20.75 | $19.9M |
| 2024 | $2.1B | -$825.5M | -$14.93 | -$67.2M |
| 2023 | $1.7B | -$33.3M | -$0.61 | $12.8M |
| 2022 | $1.6B | -$13.3M | -$0.25 | -$161.3M |
| 2021 | $1.4B | $71.7M | $1.40 | $251.9M |
| 2020 | $1.1B | $42.6M | $0.93 | $187.2M |
Latest SEC filings
What Enovis CORP has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 1, 2026
- August 14, 2026Passive stake (5% or more) SCHEDULE 13G
- August 6, 2026Quarterly report 10-Q · period to July 3, 2026
- August 6, 2026
- July 28, 2026Passive stake changed SCHEDULE 13G/A
- July 8, 2026Passive stake changed SCHEDULE 13G/A
- June 26, 2026
- May 28, 2026
- May 19, 2026
- May 19, 2026
Questions about ENOV
What does Enovis CORP do?
Enovis CORP is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NYSE under the ticker ENOV.
Is Enovis CORP profitable?
No. Over the twelve months to July 3, 2026 it reported a net loss of $1.1B on revenue of $2.3B.
How much revenue does Enovis CORP make?
Over the twelve months to July 3, 2026 Enovis CORP reported revenue of $2.3B. That is 4.9% more than a year earlier.
When did Enovis CORP last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to July 3, 2026. Its newest filing of any kind is the insider trade from September 8, 2026.
Similar companies
Follow ENOV
Get an email when Enovis CORP files with the SEC: results, executive changes, material agreements and annual reports.
Follow ENOV: get an email when it filesWhere the numbers come from
Financial figures are the values Enovis CORP tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.